Today is Tuesday, September 07, 2010
Today's date:
Tuesday
September 07, 2010
Tuesday, September 07, 2010
09/07/2010
Tuesday
09/07/2010
September 07, 2010
September 07
07-Sep-2010
Our Physicians
Areas of Expertise
Patient Login
About Us
Location & Contact Info
Tower News
Patient Education
Urology Resources
Upcoming Events
Research
Medical Resources
Newsletter Sign-up
Search





Tower Urology Institute for Minimally Invasive and Robotic Surgery - Surgical Innovations for Kidney and Prostate Cancer.

Matthew Bui, M.D. Ph.D.
Christopher S. Ng, M.D.

Minimally invasive surgery is quickly becoming the standard of care in multiple surgical subspecialties, and this is particularly true in the field of Urology. The indications for open surgery are becoming less common as minimally invasive options become available. Many innovations are revolutionizing the way we treat kidney and prostate cancer through laparoscopic and robotic surgeries. Currently, urologists are able to remove cancers of the kidney and prostate through pencil-sized incisions with efficacy equal to open surgery. Through laparoscopic or robotic surgery, the entire operation is performed internally through small (about one-half inch) incisions. This approach greatly reduces postoperative pain and facilitates recovery and an earlier return to normal activity.

There will be over 38,000 newly diagnosed cases of kidney cancer in 2007. This cancer is not responsive to radiation treatment or chemotherapy. Surgery often renders a cure when the tumor is confined within the kidney. Surgery may involve removing the entire kidney if the tumor is large or only the cancerous part through a partial resection if the tumor is small. Laparoscopic surgery can accomplish these goals through tiny incisions that greatly reduce pain and shorten recovery time. Most patients can leave the hospital the day after laparoscopic surgery and are able to return to normal activity by several weeks.

Prostate cancer is the most common cancer in men, with over 236,000 newly diagnosed cases in 2006, and is the third-leading cause for cancer deaths in men. The decision, of how and when to treat, depends upon the individual's age, current health status and cancer characteristics. If the cancer is confined to the prostate, there is the possibility of cure through prostate removal surgery called prostatectomy. Robotic-assisted laparoscopic prostatectomy (also known as da Vinci® prostatectomy) is a state-of-the-art system that is available at centers of excellence such as Cedars-Sinai Medical Center. In 2006, over 85,000 prostatectomies will be performed in the US, of which over 1/3 will be done robotically. Robotic prostatectomy provides the benefits of laparoscopic surgery in addition to enhanced visualization and precision. During the surgery, the surgeon is seated at a console that permits a 3-D view with a 10 to 15-times magnification of the operative field. The computer-enhanced system scales the hand movements of surgeon down to micromovements of the surgical instruments. This technology allows for surgical precision for tumor removal and preservation of delicate nerves and vital blood vessels. Due to the minimal discomfort and debilitation, most patients are able to leave the hospital the day after surgery.

Dr. Bui and Dr. Ng are the directors of the Institute for Minimally Invasive Surgery at Tower Urology. They are available for consultation Monday through Friday and can be reached at (310) 854-9898.

Tower Urology is located at 8635 West 3rd St, Suite 1 West, Los Angeles, adjacent to Cedars-Sinai Medical Center. www.towerurology.com





Terms and Conditions | Feedback | Privacy Statement
Developed and hosted by Urology Domain.
© Copyright 2000-2010. NorthPoint Domain Inc. All rights reserved.
ICS-PR-WEB01